Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Immune Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07829497
What this trial is testing

Pain Phenotyping of Rheumatic Diseases - An Observational Study

Who this might be right for
Rheumatic DiseasesLupus Erythematosus, SystemicLupus Vasculitis, Central Nervous System+5 more
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 225
Not applicableEnded earlyNCT04141046
What this trial is testing

LUPUS Brain: tACS to Target the Neurophysiology of Depression, Cognitive Deficits, and Pain in Patients With SLE

Who this might be right for
Systemic Lupus ErythematosusDepression
University of North Carolina, Chapel Hill 4
Not applicableUnknownNCT03939273
What this trial is testing

The Effects of Gut Micribiota Disruption on the Immune Response After Open Heart Surgery

Who this might be right for
Systemic Inflammatory Response SyndromePostoperative ShockCoronary Artery Disease+1 more
Radboud University Medical Center 80
Not applicableLooking for participantsNCT06837454
What this trial is testing

French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Sanofi 600
Early research (Phase 1)Looking for participantsNCT07236762
What this trial is testing

An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis (LN)Sjogren's Syndrome+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Early research (Phase 1)Looking for participantsNCT06285279
What this trial is testing

The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases

Who this might be right for
Lupus NephritisANCA-associated VasculitisMembranous Nephropathy - PLA2R Induced+1 more
Nanjing University School of Medicine 24
Large-scale testing (Phase 3)UnknownNCT05631717
What this trial is testing

The Study of Comparing the Efficacy and Safety of Human Umbilical Cord MSCs and Low-dose IL-2 in the Treatment of LN

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 40
Not applicableLooking for participantsNCT00198068
What this trial is testing

Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)

Who this might be right for
Systemic Lupus ErythematosusAntiphospholipid Syndrome
Hospital for Special Surgery, New York 700
Early research (Phase 1)Looking for participantsNCT07284797
What this trial is testing

Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases

Who this might be right for
HealthyIdiopathic Inflammatory MyopathiesSystemic Sclerosis+1 more
Xencor, Inc. 60
Early research (Phase 1)Study completedNCT06144710
What this trial is testing

SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Hangzhou Sumgen Biotech Co., Ltd. 48
Testing effectiveness (Phase 2)Study completedNCT03406468
What this trial is testing

Re-Induction After Initial Response With Immune Therapy With Radiotherapy in Lung Cancer

Who this might be right for
Non-Small Cell Carcinoma of Lung, TNM Stage 4
Maastricht Radiation Oncology 36
Early research (Phase 1)Study completedNCT01516450
What this trial is testing

Japanese phase1 Study of Belimumab (IV vs SC)

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 16
Not applicableStudy completedNCT00582465
What this trial is testing

Study to Evaluate the Natural History of Osteoporosis in Children and Adolescents With Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
University of California, San Francisco 243
Post-approval studies (Phase 4)Active Not RecruitingNCT06677801
What this trial is testing

Immune Cell Subsets in SLE Patients Treated with Telitacicept

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Second Affiliated Hospital, Zhejiang University, School of Medicine 50
Large-scale testing (Phase 3)Study completedNCT05001737
What this trial is testing

Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE

Who this might be right for
Macrophage Activation SyndromeSecondary Hemophagocytic LymphohistiocytosisStill Disease+4 more
Swedish Orphan Biovitrum 33
Not applicableStudy completedNCT06560775
What this trial is testing

Effects of Nigella Sativa on T Cells and Cytokine Profile in Pediatric SLE Patients

Who this might be right for
SLE (Systemic Lupus)
University of Brawijaya 32
Early research (Phase 1)Study completedNCT01231919
What this trial is testing

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more
National Cancer Institute (NCI) 45
Post-approval studies (Phase 4)UnknownNCT05505409
What this trial is testing

Efficacy and Safety of Pirfenidone in CTD-ILD

Who this might be right for
PirfenidoneConnective Tissue DiseasesInterstitial Lung Disease
Qilu Hospital of Shandong University 120
Testing effectiveness (Phase 2)Looking for participantsNCT06535412
What this trial is testing

IMC-002 for the Treatment of Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd. 218
Testing effectiveness (Phase 2)Study completedNCT00266565
What this trial is testing

Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome

Who this might be right for
Hypereosinophilic SyndromesEosinophilic GastroenteritisChurg-Strauss Syndrome+1 more
Children's Hospital Medical Center, Cincinnati 24
Next Page